212 related articles for article (PubMed ID: 16679425)
1. Considerations in the long-term management of asthma in ambulatory patients.
Williams DM
Am J Health Syst Pharm; 2006 May; 63(10 Suppl 3):S14-21. PubMed ID: 16679425
[TBL] [Abstract][Full Text] [Related]
2. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
3. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
Hancox RJ; Taylor DR
BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
[TBL] [Abstract][Full Text] [Related]
6. [Asthma treatment in childhood: from guidelines to practice].
de Blic J
Arch Pediatr; 2004 Jun; 11 Suppl 2():107s-112s. PubMed ID: 15301807
[TBL] [Abstract][Full Text] [Related]
7. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
8. Non-corticosteroid therapy for the long-term control of asthma.
Kelly HW
Expert Opin Pharmacother; 2007 Sep; 8(13):2077-87. PubMed ID: 17714061
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of bronchial asthma.
Nelson HS
Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
[TBL] [Abstract][Full Text] [Related]
10. Medical Therapy for Asthma: Updates from the NAEPP Guidelines.
Elward KS; Pollart SM
Am Fam Physician; 2010 Nov; 82(10):1242-51. PubMed ID: 21121536
[TBL] [Abstract][Full Text] [Related]
11. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
Chantaphakul H; Ruxrungtham K
Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based asthma management.
Kallstrom TJ
Respir Care; 2004 Jul; 49(7):783-92. PubMed ID: 15222910
[TBL] [Abstract][Full Text] [Related]
13. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
Naedele-Risha R; Dorinsky P; Craig TJ
J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
15. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
16. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
[TBL] [Abstract][Full Text] [Related]
17. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
National Asthma Education and Prevention Program
J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
[TBL] [Abstract][Full Text] [Related]
18. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of bronchial asthma in adults.
Rosa JD; Chandy D; Aronow WS; DeLorenzo LJ
Compr Ther; 2008; 34(1):10-7. PubMed ID: 18681106
[TBL] [Abstract][Full Text] [Related]
20. Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids.
Ducharme FM; Gagnon R; Bénard B; Tse SM; Thivierge R
Eur Respir J; 2016 Aug; 48(2):558-60. PubMed ID: 27230440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
